bullish

Japan Weekly | IHI, Sumi Pharma, Toho, Sawai, JEOL

255 Views29 Jun 2024 05:34
​Mixed signals in U.S. economy as Q1 GDP grows to 1.4%, but jobless claims rise; Japan's Nikkei 225 sees strong performance despite dollar-yen depreciation
What is covered in the Full Insight:
  • U.S. Economic Outlook
  • Nikkei 225 Performance
  • Stock Movement Highlights
  • Upcoming Market Factors
  • Company-Specific Developments
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Logo
Top 5%
Mark Chadwick
Japan Specialist
JapanEquitiesESG
  • Japan Weekly | IHI, Sumi Pharma, Toho, Sawai, JEOL
    29 Jun 2024
x